A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma
Susumu Yamasaki(Tokyo National Hospital), Toshiharu Tsuzuki(Keio University), Takashi Kanematsu(Kyushu University), Hiroshi Hasegawa(Shibaura Institute of Technology), Masato Furukawa, Masayuki Yamamoto(Tohoku University), Kenji Ikeda(Toranomon Hospital), Morito Monden(Unknown), Ken Takasaki, Munemasa Ryu(Chiba Cancer Center), Youichiro Kakumoto(Nippon Koei (Japan)), Shingi Imaoka(Osaka International Cancer Institute), Hiroaki Kinoshita(Breast Cancer Research Foundation), Shigeki Arii(Kyoto University), Ryusaku Yamada(Osaka City University), Takeo Saoshiro(National Hospital Organization), S Kusano(National Defense Medical College), Eizo Okamoto(Hyogo Medical University), Yukio Oosaki(Osaka Red Cross Hospital)
Cited by 154
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
|Cancer|1985|1.9k
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
|Nature Communications|2016|1.8k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k